tiprankstipranks
Qualigen Therapeutics Inc (QLGN)
NASDAQ:QLGN

Qualigen Therapeutics (QLGN) Stock Price & Analysis

540 Followers

QLGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.34 - $1.26
Previous Close$0.4
Volume79.81K
Average Volume (3M)60.13K
Market Cap
$2.07M
Enterprise Value$5.25M
Total Cash (Recent Filing)$1.30M
Total Debt (Recent Filing)$3.20M
Price to Earnings (P/E)-0.1
Beta0.32
Mar 29, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.58
Shares Outstanding5,181,058
10 Day Avg. Volume104,163
30 Day Avg. Volume60,132
Standard Deviation0.37
R-Squared0.01
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-1.26
Price to Sales (P/S)0.42
Price to Cash Flow (P/CF)0.50
P/FCF Ratio0.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.87
Enterprise Value/Gross Profit1.05
Enterprise Value/Ebitda-0.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

QLGN FAQ

What was Qualigen Therapeutics Inc’s price range in the past 12 months?
Qualigen Therapeutics Inc lowest stock price was $0.34 and its highest was $1.26 in the past 12 months.
    What is Qualigen Therapeutics Inc’s market cap?
    Currently, no data Available
    When is Qualigen Therapeutics Inc’s upcoming earnings report date?
    Qualigen Therapeutics Inc’s upcoming earnings report date is Mar 29, 2024 which is 19 days ago.
      How were Qualigen Therapeutics Inc’s earnings last quarter?
      Qualigen Therapeutics Inc released its earnings results on Nov 14, 2023. The company reported -$0.72 earnings per share for the quarter, beating the consensus estimate of -$0.92 by $0.2.
        Is Qualigen Therapeutics Inc overvalued?
        According to Wall Street analysts Qualigen Therapeutics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Qualigen Therapeutics Inc pay dividends?
          Qualigen Therapeutics Inc does not currently pay dividends.
          What is Qualigen Therapeutics Inc’s EPS estimate?
          Qualigen Therapeutics Inc’s EPS estimate is -$0.52.
            How many shares outstanding does Qualigen Therapeutics Inc have?
            Qualigen Therapeutics Inc has 5,181,058 shares outstanding.
              What happened to Qualigen Therapeutics Inc’s price movement after its last earnings report?
              Qualigen Therapeutics Inc reported an EPS of -$0.72 in its last earnings report, beating expectations of -$0.92. Following the earnings report the stock price went up 5.714%.
                Which hedge fund is a major shareholder of Qualigen Therapeutics Inc?
                Currently, no hedge funds are holding shares in QLGN
                ---

                Qualigen Therapeutics Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -55.05%
                12-Months-Change

                Fundamentals

                Return on Equity
                -321.20%
                Trailing 12-Months
                Asset Growth
                -81.20%
                Trailing 12-Months

                Company Description

                Qualigen Therapeutics Inc

                Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                ADMA Biologics
                BioCryst
                BioNTech SE
                Cidara Therapeutics
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis